Increased formation of F(2)-isoprostanes in patients with severe heart failure.

Increased formation of F(2)-isoprostanes in patients with severe heart failure.

Item
http://www.wikidata.org/entity/Q35376458
Diminished antioxidant activity of high-density lipoprotein-associated proteins in systolic heart failureIncreased urinary 15-F2t-isoprostane concentrations in patients with non-ischaemic congestive heart failure: a marker of oxidative stress.Isoprostanes: novel bioactive products of lipid peroxidation.Low-sodium dietary approaches to stop hypertension diet reduces blood pressure, arterial stiffness, and oxidative stress in hypertensive heart failure with preserved ejection fraction.Cardiovascular pharmacology and physiology of the isoprostanes.Effect of pre- and postnatal exposure to urban air pollution on myocardial lipid peroxidation levels in adult mice.The putative role of isoprostanes in human cardiovascular physiology and disease: following the fingerprints.Increased urinary F2-isoprostanes in patients with Crohn's disease.Enhanced oxidative stress in coronary heart disease and chronic heart failure as indicated by an increased 8-epi-PGF(2alpha).The enigma of in vivo oxidative stress assessment: isoprostanes as an emerging target.Markers of oxidative damage in chronic heart failure: role in disease progression.Serum paraoxonase activity in patients with ischaemic and nonischaemic dilated cardiomyopathy.
P2860

Increased formation of F(2)-isoprostanes in patients with severe heart failure.

Item
http://www.wikidata.org/entity/Q35376458
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Increased formation of F(2)-isoprostanes in patients with severe heart failure.
@ast
Increased formation of F(2)-isoprostanes in patients with severe heart failure.
@en
type
label
Increased formation of F(2)-isoprostanes in patients with severe heart failure.
@ast
Increased formation of F(2)-isoprostanes in patients with severe heart failure.
@en
prefLabel
Increased formation of F(2)-isoprostanes in patients with severe heart failure.
@ast
Increased formation of F(2)-isoprostanes in patients with severe heart failure.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932
P356
P1433
P1476
Increased formation of F(2)-isoprostanes in patients with severe heart failure.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932